National service evaluation for paclitaxel HSRs

Dear BOPA members,

We are all very aware of concerns from our members regarding the ongoing supply shortages of ranitidine. Many hospitals will be forced to amend pre-medication regimens to an alternative where there is sparse experience and it is imperative that we collect data that assures us that patient safety is not compromised.

As Co-chair of BOPA, I would like to invite you to take part in a national service evaluation of paclitaxel pre-medication regimes designed by myself in collaboration with Calum Polwart and Pinkie Chambers. Calum has created a bespoke data collection tool (in Excel format) to minimise the administrative burden.

We strongly encourage you to collaborate on this project, so collectively we can gain a better understanding of the impact of changes in practice results from the shortage.

What to do next?

Email me to let us know you are participating ([email protected]). I will send you the data collection tool and an instruction sheet for participants, and we can then keep in touch with you throughout the evaluation period.

Although we have logged the evaluation with the BOPA executive committee and A&R subcommittee, you will still need to register your data collection as a service evaluation at your Trust.

Data collection will take place over a six-month period from 1st July to 31st December (the end date may be amended depending on the amount of data received). We will keep a check on numbers collected and complete an interim analysis as soon as possible. Results of the interim analysis as well as the final results will be presented to participating centres in a timely fashion to assist in clinical decision-making.

If you have any concerns or queries, please contact a member of the team via the email addresses given below.

I will look forward to hearing from you!

Best Wishes

Emma Foreman
Co-chair, British Oncology Pharmacy Association
www.bopa.org.uk

Contacts:
[email protected]
[email protected]
[email protected]
[email protected]

Latest News

By BOPA Executive Committee on 15th July 2025

BSH Membership Survey 2025 – Pharmacy input required!

BOPA Members, As part of our ongoing  and increased collaborations with the British Society of Haematology (BSH) we would like to circulate the BSH Membership Survey 2025.  BSH are seeking…

Read article
By BOPA Immunotherapy Specialist Advisory Group on 14th July 2025

IOCN and UKSACT Board joint letter to NHSE

Hello All One of the pressing issues the BOPA Immunotherapy Specialist Advisory Group has been working over the past year, is addressing/improving the access to second line immunosuppressants for the…

Read article
By BOPA Committee on 14th July 2025

2025 Elections to the BOPA Executive Committee: Call for nomination of members

BOPA is looking for new Executive Committee members who are dedicated to furthering the association’s aims and who are willing, and able, to spend time helping run the organisation. Those…

Read article
By BOPA committee on 10th July 2025

Update to BOPA Standards – New Guidance on Pharmacy Technician SACT Verification (Section 3.3)

Dear BOPA Members, We are pleased to share an important update to the BOPA Standards for the Pharmacy Verification of Prescriptions for Cancer Medicines (Version 5.0, 3 June 2025). A…

Read article